Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

207
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
207
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

174
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
174
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

997
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
997
Pleura of the Lungs01:13

Pleura of the Lungs

1.9K
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
1.9K
Pneumothorax-II01:27

Pneumothorax-II

146
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
146
Other Pulmonary Disorders01:17

Other Pulmonary Disorders

839
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
839

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiogenic Shock and Symmetrical Peripheral Gangrene in Relapsed Follicular Lymphoma: A Case Report With Bordetella bronchiseptica Co-infection.

Cureus·2026
Same author

Disseminated Fungal Infection in Profoundly Immunocompromised Hosts: A Three-Case Series.

Cureus·2026
Same author

<i>Mycobacterium avium</i> complex lung infection mimics lung cancer nodules but improves after antibiotic therapy: a case series.

Frontiers in medicine·2026
Same author

Beyond Infection and Malignancy: Diagnostic Pitfalls in Pulmonary Granulomatosis with Polyangiitis.

Cureus·2026
Same author

Purpura Fulminans Due to Escherichia coli Septicemia in Relapsed Acute Myeloid Leukemia: An Unusual Case of Protein C Deficiency and Disseminated Intravascular Coagulation.

Cureus·2025
Same author

Giardiasis in the Immunocompromised: A Case Series Highlighting Diagnostic Pitfalls and Treatment Challenges.

Cureus·2025
Same journal

A hypermetabolic pulmonary lesion in a patient with breast cancer.

Breathe (Sheffield, England)·2026
Same journal

Rigid bronchoscopy is the gold standard management of inhaled foreign bodies in children: myth or maxim?

Breathe (Sheffield, England)·2026
Same journal

The price of immune awakening: bridging knowledge gaps in checkpoint inhibitor-related pneumonitis in lung cancer.

Breathe (Sheffield, England)·2026
Same journal

Where are we with biomarkers in paediatric asthma in 2026?

Breathe (Sheffield, England)·2026
Same journal

Recurrent invasive fungal infection with locally advanced thymoma: diagnostic challenges in complex mediastinal disease.

Breathe (Sheffield, England)·2026
Same journal

Elevated <i>D</i> <sub>LCO</sub> and pulmonary function evolution during treatment in a patient with hyperleukocytosis and leukostasis.

Breathe (Sheffield, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.9K

Malignant pleural disease.

Laura M Piggott1,2,3, Conor Hayes1,2,3, John Greene4

  • 1Department of Respiratory Medicine, Tallaght University Hospital, Dublin, Ireland.

Breathe (Sheffield, England)
|February 14, 2024
PubMed
Summary
This summary is machine-generated.

Malignant pleural disease, including malignant pleural effusion, impacts 1 million people yearly. Early diagnosis and holistic management are crucial for symptom relief and improved quality of life in these patients.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.9K
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

688

Related Experiment Videos

Last Updated: Jul 3, 2025

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.9K
Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

6.9K
Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion
03:22

Local Anesthetic Thoracoscopy for Undiagnosed Pleural Effusion

Published on: November 10, 2023

688

Area of Science:

  • Pulmonology
  • Oncology

Background:

  • Malignant pleural disease is a significant and increasing global health concern.
  • Malignant pleural effusion affects approximately 1 million individuals annually, leading to severe breathlessness and reduced life expectancy.

Purpose of the Study:

  • To review the epidemiology, pathogenesis, and diagnostic strategies for malignant pleural disease.
  • To outline management options for malignant pleural effusion and malignant pleural mesothelioma.
  • To address challenges in managing complex cases like non-expandable lung and septated effusions.

Main Methods:

  • Literature review of epidemiology, pathogenesis, diagnosis, and management of malignant pleural disease.
  • Synthesis of current evidence on diagnostic pathways.
  • Overview of therapeutic interventions for malignant pleural effusion and mesothelioma.

Main Results:

  • Malignant pleural effusion is a common condition with significant morbidity.
  • Timely diagnosis and individualized patient factors are key for effective management.
  • A holistic approach is necessary, considering challenges such as non-expandable lungs and septated effusions.

Conclusions:

  • Effective management of malignant pleural disease requires a comprehensive understanding of its epidemiology and pathogenesis.
  • Optimizing quality of life necessitates prompt diagnosis and tailored treatment strategies.
  • Addressing specific clinical challenges is vital for successful patient outcomes.